TORRENT PHARMS LTD FDA Approval ANDA 091654

ANDA 091654

TORRENT PHARMS LTD

FDA Drug Application

Application #091654

Application Sponsors

ANDA 091654TORRENT PHARMS LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002
None (Tentative Approval)003
None (Tentative Approval)004
None (Tentative Approval)005

Application Products

001TABLET; ORAL80MG; 12.5MG0VALSARTAN; HYDROCHLOROTHIAZIDEVALSARTAN; HYDROCHLOROTHIAZIDE
002TABLET; ORAL160MG; 12.5MG0VALSARTAN; HYDROCHLOROTHIAZIDEVALSARTAN; HYDROCHLOROTHIAZIDE
003TABLET; ORAL160MG; 25MG0VALSARTAN; HYDROCHLOROTHIAZIDEVALSARTAN; HYDROCHLOROTHIAZIDE
004TABLET; ORAL320MG; 12.5MG0VALSARTAN; HYDROCHLOROTHIAZIDEVALSARTAN; HYDROCHLOROTHIAZIDE
005TABLET; ORAL320MG; 25MG0VALSARTAN; HYDROCHLOROTHIAZIDEVALSARTAN; HYDROCHLOROTHIAZIDE

FDA Submissions

ORIG1TA2012-04-10

Submissions Property Types

ORIG1Null0

CDER Filings

TORRENT PHARMS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 91654
            [companyName] => TORRENT PHARMS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"VALSARTAN; HYDROCHLOROTHIAZIDE","activeIngredients":"VALSARTAN; HYDROCHLOROTHIAZIDE","strength":"80MG; 12.5MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VALSARTAN; HYDROCHLOROTHIAZIDE","activeIngredients":"VALSARTAN; HYDROCHLOROTHIAZIDE","strength":"160MG; 12.5MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VALSARTAN; HYDROCHLOROTHIAZIDE","activeIngredients":"VALSARTAN; HYDROCHLOROTHIAZIDE","strength":"160MG; 25MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VALSARTAN; HYDROCHLOROTHIAZIDE","activeIngredients":"VALSARTAN; HYDROCHLOROTHIAZIDE","strength":"320MG; 12.5MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"VALSARTAN; HYDROCHLOROTHIAZIDE","activeIngredients":"VALSARTAN; HYDROCHLOROTHIAZIDE","strength":"320MG; 25MG","dosageForm":"TABLET; ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"VALSARTAN; HYDROCHLOROTHIAZIDE","submission":"VALSARTAN; HYDROCHLOROTHIAZIDE","actionType":"80MG; 12.5MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"},{"actionDate":"VALSARTAN; HYDROCHLOROTHIAZIDE","submission":"VALSARTAN; HYDROCHLOROTHIAZIDE","actionType":"160MG; 12.5MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"},{"actionDate":"VALSARTAN; HYDROCHLOROTHIAZIDE","submission":"VALSARTAN; HYDROCHLOROTHIAZIDE","actionType":"160MG; 25MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"},{"actionDate":"VALSARTAN; HYDROCHLOROTHIAZIDE","submission":"VALSARTAN; HYDROCHLOROTHIAZIDE","actionType":"320MG; 12.5MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"},{"actionDate":"VALSARTAN; HYDROCHLOROTHIAZIDE","submission":"VALSARTAN; HYDROCHLOROTHIAZIDE","actionType":"320MG; 25MG","submissionClassification":"TABLET; ORAL","reviewPriority":"None (Tentative Approval)","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.